Nyhet

Exciting news from Swecare member Neobiomics, which has announced a new investment led by HealthCap, one of Europe’s leading life science venture capital investors.

The investment will support the company’s continued commercial expansion, international growth, and further development of its portfolio focused on neonatal and pediatric health. Neobiomics develops evidence-based nutritional products designed to improve outcomes for preterm infants and other vulnerable patient groups.

This milestone reflects the strength of Swedish life science innovation and highlights how research-driven companies can translate clinical evidence into solutions that make a real difference in healthcare. It also demonstrates the growing international interest in Swedish expertise within neonatal care.

At Swecare, we are proud to see our members contributing to better health outcomes globally and helping bring Swedish knowledge, innovation, and healthcare solutions to patients around the world. Congratulations to the Neobiomics team on this important achievement.

Read Neobiomics pressrelease here: Pressrelease.